EXA5758, EX-A5758, EX-A-5758, EX-A 5758, EX A5758, nNOS/NOS1 AP
EX-A5758 is a novel small molecule inhibitor targeting nNOS-NOS1AP. It demonstrates efficacy in suppressing inflammatory and chemotherapy-induced neuropathic pain in vivo and synergizes with paclitaxel to reduce tumor cell viability in vitro, highlighting its potential in pain and oncology research.